Integrum AB, the Swedish medtech company best known for its OPRA™ Implant System, is betting that better language—not just better hardware—can accelerate adoption of bone-anchored prosthetics. At the American Orthotic & Prosthetic Association’s National Assembly in Orlando, the company rolled out a global marketing strategy built around a new term: BondedMatrix™.

The phrase isn’t describing a new feature so much as a new way of talking about what OPRA already does: integrate soft tissue and bone into a stable, long-term connection. It’s the biological barrier formed after healing that makes OPRA stand apart from conventional socket-based prosthetics and rival implant systems. Now, instead of a mouthful of surgical and biomechanical jargon, clinicians and patients can point to a simple, memorable label.

Why Naming Matters

For years, OPRA’s differentiator has been its ability to create a dependable, dry skin-to-implant interface—something that matters deeply for amputees worried about infections and long-term comfort. But the benefits have often been buried in technical language. “This initiative is about creating a common language that makes OPRA’s advantages more accessible,” said Jeffrey Zanni, President of Integrum Inc.

It’s not just marketing gloss. By coining BondedMatrix™, Integrum hopes to give doctors, prosthetists, and patients a shorthand that drives both clinical trust and patient demand. Think of it as branding the invisible—but critical—layer of protection that’s been part of OPRA since its inception.

Market Context

The timing is telling. With over 1,000 OPRA implants already placed worldwide and decades of refinement by Dr. Rickard Brånemark, Integrum is trying to expand awareness as competition in advanced prosthetics heats up. Rival systems often tout modular upgrades or advanced materials, but they still struggle to achieve consistent long-term skin-bone integration.

“Patients want a dependable and dry skin-implant interface—a BondedMatrix,” said Dr. Jason Souza of Ohio State University, a leading voice in amputation care. “The OPRA Implant System is the only one that can reliably deliver it.”

What’s Next

Beyond the rebrand, Integrum is doubling down on education. At booth #931 during AOPA 2025, the company is offering live discussions and resources for clinicians. A dedicated dinner session led by Dr. Souza will spotlight patient outcomes and real-world performance of OPRA implants.

Whether BondedMatrix™ sticks as a household term remains to be seen. But in a space where trust, reliability, and long-term outcomes drive adoption, giving people the language to demand the right technology might be as important as the implants themselves.

Get in touch with our MarTech Experts.